The first “2018 Sino-US Cancer Immunotherapy Forum” co-sponsored by the American Chinese Association of Hematology and Oncology Experts (CAHON) and the First Affiliated Hospital of ZZU was held on July 3 on Zhengdong Campus of the Affiliated Hospital. Present at the meeting were Academician of the Chinese Academy of Engineering, Prof. Yang Shengli of the First Affiliated Hospital, Foreign Academician of the Chinese Academy of Sciences, Academician of the National Academy of Sciences, Director of the Beijing Institute of Life Sciences, Prof. Wang Xiaodong, Academician of the Royal Academy of Sciences of Belgium, Dr. Benoit Vanden Eynde, Minister of Oncology of the US Food and Drug Administration ( FDA), Dr. Richard Pazdur, Deputy Director of Henan Provincial Health Planning Commission, Xie Liguang, Academician of Chinese Academy of Engineering, President Liu Jiongtian of ZZU , Vice President Gu Zhenqing, Dean Liu Zhangsuo of the First Affiliated Hospital, the former Party Secretary Zhang Shuijun of the First Affiliated Hospital and other attendees.

At the academic reporting stage, Liu Zhangsuo introduced the basic situation of the Affiliated Hospital and the status quo and prospects of international exchanges; Dr. Richard Pazdur explained the importance of accelerating the development of oncology drugs in the era of therapy breakthrough from the historical perspective of the FDA; Professor Li Zihai from the First Affiliated Hospital, based on his own work, made a report “On the Role of Blood Disease of Chinese Americans and CAHON in Linking Research and Treatment of Chinese and American Tumors”.

Experts and scholars at the conference also made special reports and discussions on topics such as tumor immunotherapy, cooperation opportunities and strategies in the field of tumor between China and the United States, and discussed the prospects of cooperation between the First Affiliated Hospital of ZZU and CAHON as well as the positive effects on the construction of a first-class university. (translator Song Gencheng)